General Pharmaceuticals Ltd (GPL) launched its 'Linaptin' brand in Sri Lanka pharma market recently, said a statement.
Under this intiative, the Bangladeshi company will be able to increase its product portfolio to the Sri Lanka market.
At present, GPL has 27 registered products in Sri Lanka market which was opened to the Bangladeshi company in 2007.
"More pharmaceutical products from our company will be exported to Sri Lanka in near future," the statement added.
-rmc//